EUVIMEDEUVIMED entdecken
Crossref

Deferoxamine attenuates ferroptosis and oxidative injury during normothermic perfusion of human donor livers

Mustafa Nazzal, Kento Kurashima, Shun Onishi, Shaurya Mehta, Jeffery Bettag, Aakash Nagarapu, Joseph Krebs, Johan Van Nispen, Ashlesha Bagwe, Takahiro Ohkura, Marzena Swiderska‐Syn, Loren Po und 9 weitere

Journal of Pediatric Gastroenterology and Nutrition · 20.11.2026

DOI: 10.1002/jpn3.70636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 20.11.2026. Verfasst von Mustafa Nazzal und 20 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Gefördert von: National Institutes of Health, Liver Center, Saint Louis University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Marginal donor livers (MDLs) are highly susceptible to ischemia–reperfusion injury (IRI), in which ferroptosis, an iron‐dependent form of cell death, plays a key role. We tested the hypothesis that iron chelation with deferoxamine (DFO) attenuates ferroptosis and reduces injury in human MDLs using ex vivo perfusion.

Methods

Split lobes from six human MDLs were perfused utilizing the novel Perfusion Regulated Organ Therapeutics with Enhanced Controlled Testing (PROTECT) system, with one lobe receiving DFO (0.6 mmol/L; single or dual dosing) and the contralateral lobe serving as control. Outcomes included iron content, ferroptosis‐related gene and protein expression, apoptosis (TUNEL), lipid peroxidation (malondialdehyde [MDA]), and hepatocellular injury.

Results

DFO achieved iron chelation, with ≥20% reduction in iron versus controls. Chelated lobes demonstrated downregulation of ferroptosis‐related genes including HIF‐1α, IREB2, RPL8, FTH1, ACSF2, ATP5G3 (multiple targets p < 0.0001) and reduced HIF‐1α protein expression ( p = 0.0040). This molecular shift translated into reduced tissue injury, with fewer apoptotic cells on TUNEL staining ( p = 0.0283) and decreased lipid peroxidation. Aspartate aminotransferase trended lower with DFO but did not reach significance ( p = 0.0727). In contrast, non‐chelated lobes ( n = 8) demonstrated persistent iron accumulation, upregulation of ferroptosis pathways, and increased apoptosis and oxidative stress. Stratified analysis confirmed that iron reduction was associated with suppression of ferroptosis gene expression (multiple targets, p = 0.0040–0.0485) and lower injury markers. Dual dosing improved chelation efficacy (2/2 vs. 2/4 single dose), and protective effects were observed in steatotic livers.

Conclusions

DFO‐mediated iron chelation reduces ferroptosis signaling and early IRI in human MDLs. Targeting iron‐dependent pathways may improve viability and utilization of high‐risk donor livers.

Förderung

  • National Institutes of Health
  • Liver Center, Saint Louis University

Zitieren

APA

Nazzal, M., Kurashima, K., Onishi, S., Mehta, S., Bettag, J., Nagarapu, A., Krebs, J., Nispen, J. V., Bagwe, A., Ohkura, T., Swiderska‐Syn, M., Po, L., Whalen, C., Jain, A., Besmer, S., Guzman, M., Buchanan, P., Caliskan, Y., Teckman, J., …, & Jain, A. K. (2026). Deferoxamine attenuates ferroptosis and oxidative injury during normothermic perfusion of human donor livers. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70636

Vancouver

Nazzal M, Kurashima K, Onishi S, Mehta S, Bettag J, Nagarapu A, et al. Deferoxamine attenuates ferroptosis and oxidative injury during normothermic perfusion of human donor livers. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70636

BibTeX
@article{Nazzal2026,
  author = {Nazzal, Mustafa and Kurashima, Kento and Onishi, Shun and Mehta, Shaurya and Bettag, Jeffery and Nagarapu, Aakash and Krebs, Joseph and Nispen, Johan Van and Bagwe, Ashlesha and Ohkura, Takahiro and Swiderska‐Syn, Marzena and Po, Loren and Whalen, Connor and Jain, Aditya and Besmer, Sherri and Guzman, Miguel and Buchanan, Paula and Caliskan, Yasar and Teckman, Jeffery and Manithody, Chandrashekhara and Jain, Ajay Kumar},
  title = {Deferoxamine attenuates ferroptosis and oxidative injury during normothermic perfusion of human donor livers},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70636}
}
Kostenlos starten →